Update: 19.07.2022
Last week: 27 week 2022 (04.07.2022 - 10.07.2022)
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 103 158 | -15.4% | 6.2% | -0.3 | 20 082 468 | -15.2% | 5.7% | -0.3 | -11.0% |
| MoM | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| YTD | 6 197 034 | 34.8% | 6.0% | 0.9 | 1 224 954 912 | 60.5% | 5.7% | 1.2 | 14.6% |
| MAT | 14 867 840 | 54.3% | 6.7% | 1.8 | 2 752 559 466 | 82.6% | 6.3% | 2 | 12.2% |
| DEXALGIN | |||||||||
| WoW | 25 580 | -12.1% | 0.7% | -0.1 | 10 826 689 | -13.3% | 1.8% | -0.2 | -4.7% |
| MoM | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| YTD | 1 093 090 | 30.8% | 0.8% | 0.1 | 452 445 561 | 42.7% | 2.1% | 0.3 | 10.7% |
| MAT | 2 096 074 | 9.4% | 0.8% | 0 | 836 384 367 | 17.7% | 2.1% | 0.1 | 5.1% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 70 594 | -11.2% | 56.9% | -0.8 | 35 730 505 | -12.8% | 62.4% | -1.5 | -10.0% |
| MoM | 336 051 | -12.5% | 56.7% | -0.6 | 172 180 989 | -12.1% | 62.6% | 0.5 | -11.5% |
| YTD | 2 805 939 | 8.5% | 58.7% | -8.1 | 1 414 921 888 | 22.8% | 64.1% | -6 | 23.5% |
| MAT | 5 501 474 | 10.4% | 61.6% | -4.5 | 2 687 068 707 | 25.9% | 67.1% | -3 | 18.4% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 984 | -9.1% | 37.9% | -1.5 | 13 854 786 | -9.1% | 50.7% | -1.6 | -5.6% |
| MoM | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| YTD | 835 529 | -3.7% | 39.1% | -3 | 513 953 409 | 2.8% | 52.5% | -4.6 | 3.6% |
| MAT | 1 631 091 | -7.1% | 39.8% | -1.2 | 985 493 669 | 2.0% | 53.7% | -1.1 | -4.3% |
| FASTUM | |||||||||
| WoW | 15 778 | -23.0% | 1.1% | -0.2 | 8 285 315 | -24.7% | 2.4% | -0.6 | -8.7% |
| MoM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| YTD | 645 838 | -12.2% | 1.2% | -0.2 | 327 119 603 | -3.3% | 2.7% | -0.4 | 3.7% |
| MAT | 1 295 091 | -13.1% | 1.3% | -0.2 | 629 166 345 | -5.2% | 2.9% | -0.3 | 0.2% |
| IODOMARIN | |||||||||
| WoW | 47 360 | -6.8% | 20.8% | -0.2 | 9 522 204 | -8.0% | 9.7% | 0 | -5.9% |
| MoM | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| YTD | 1 599 766 | 10.4% | 18.4% | 0 | 323 434 768 | 19.0% | 8.4% | 0 | 10.4% |
| MAT | 3 317 013 | 20.3% | 20.5% | 2.1 | 644 016 540 | 22.3% | 9.3% | 0.7 | 8.0% |
| LIOTON | |||||||||
| WoW | 23 072 | -14.8% | 2.4% | -0.2 | 23 896 153 | -16.8% | 4.7% | -0.6 | -6.4% |
| MoM | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| YTD | 798 793 | -10.6% | 2.5% | -0.2 | 807 880 721 | 13.2% | 5.0% | -0.4 | -3.0% |
| MAT | 1 597 946 | -9.1% | 2.7% | -0.1 | 1 497 259 094 | 10.2% | 5.4% | -0.2 | -5.1% |
| MEZYM | |||||||||
| WoW | 279 051 | -8.4% | 27.4% | -1.2 | 42 745 664 | -8.3% | 20.1% | -0.5 | -4.5% |
| MoM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| YTD | 11 611 670 | 26.9% | 29.5% | 3.7 | 1 776 205 931 | 37.2% | 21.2% | 1.8 | 10.9% |
| MAT | 23 220 379 | 26.8% | 30.9% | 4.2 | 3 390 460 539 | 32.6% | 22.5% | 2.1 | 9.7% |
| MIG 400 | |||||||||
| WoW | 133 655 | -11.0% | 3.7% | -0.3 | 15 660 235 | -11.1% | 2.6% | -0.2 | -4.7% |
| MoM | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| YTD | 4 877 525 | 10.6% | 3.5% | 0 | 571 876 001 | 13.3% | 2.7% | -0.2 | 10.7% |
| MAT | 10 359 974 | 16.6% | 3.8% | 0.4 | 1 183 670 615 | 18.8% | 2.9% | 0.2 | 5.1% |
| PROSTAMOL | |||||||||
| WoW | 20 915 | -11.7% | 18.0% | -1.3 | 28 922 942 | -11.8% | 19.3% | -1.4 | -5.5% |
| MoM | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| YTD | 980 287 | -9.1% | 20.8% | -3.6 | 1 377 635 245 | 2.4% | 22.3% | -4.6 | 6.6% |
| MAT | 2 041 447 | -3.7% | 22.7% | -1.9 | 2 732 843 586 | 4.9% | 24.2% | -2.8 | 4.2% |
| RESPERO MYRTOL | |||||||||
| WoW | 9 236 | -8.3% | 7.5% | 0.5 | 4 371 743 | -8.3% | 7.3% | 0.5 | -14.8% |
| MoM | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
| YTD | 722 668 | 207.6% | 9.1% | 5.8 | 336 557 269 | 196.9% | 8.8% | 5.1 | 10.9% |
| MAT | 1 234 507 | 114.0% | 8.0% | 3.8 | 568 061 394 | 101.9% | 7.8% | 3 | 11.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 197 034 | 34.8% | 6.0% | 0.9 | 1 224 954 912 | 60.5% | 5.7% | 1.2 | 14.6% |
| DEXALGIN | 1 093 090 | 30.8% | 0.8% | 0.1 | 452 445 561 | 42.7% | 2.1% | 0.3 | 10.7% |
| ESPUMISAN (ADULTS) | 2 805 939 | 8.5% | 58.7% | -8.1 | 1 414 921 888 | 22.8% | 64.1% | -6 | 23.5% |
| ESPUMISAN BABY | 835 529 | -3.7% | 39.1% | -3 | 513 953 409 | 2.8% | 52.5% | -4.6 | 3.6% |
| FASTUM | 645 838 | -12.2% | 1.2% | -0.2 | 327 119 603 | -3.3% | 2.7% | -0.4 | 3.7% |
| IODOMARIN | 1 599 766 | 10.4% | 18.4% | 0 | 323 434 768 | 19.0% | 8.4% | 0 | 10.4% |
| LIOTON | 798 793 | -10.6% | 2.5% | -0.2 | 807 880 721 | 13.2% | 5.0% | -0.4 | -3.0% |
| MEZYM | 11 611 670 | 26.9% | 29.5% | 3.7 | 1 776 205 931 | 37.2% | 21.2% | 1.8 | 10.9% |
| MIG 400 | 4 877 525 | 10.6% | 3.5% | 0 | 571 876 001 | 13.3% | 2.7% | -0.2 | 10.7% |
| PROSTAMOL | 980 287 | -9.1% | 20.8% | -3.6 | 1 377 635 245 | 2.4% | 22.3% | -4.6 | 6.6% |
| RESPERO MYRTOL | 722 668 | 207.6% | 9.1% | 5.8 | 336 557 269 | 196.9% | 8.8% | 5.1 | 10.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 14 867 840 | 54.3% | 6.7% | 1.8 | 2 752 559 466 | 82.6% | 6.3% | 2 | 12.2% |
| DEXALGIN | 2 096 074 | 9.4% | 0.8% | 0 | 836 384 367 | 17.7% | 2.1% | 0.1 | 5.1% |
| ESPUMISAN (ADULTS) | 5 501 474 | 10.4% | 61.6% | -4.5 | 2 687 068 707 | 25.9% | 67.1% | -3 | 18.4% |
| ESPUMISAN BABY | 1 631 091 | -7.1% | 39.8% | -1.2 | 985 493 669 | 2.0% | 53.7% | -1.1 | -4.3% |
| FASTUM | 1 295 091 | -13.1% | 1.3% | -0.2 | 629 166 345 | -5.2% | 2.9% | -0.3 | 0.2% |
| IODOMARIN | 3 317 013 | 20.3% | 20.5% | 2.1 | 644 016 540 | 22.3% | 9.3% | 0.7 | 8.0% |
| LIOTON | 1 597 946 | -9.1% | 2.7% | -0.1 | 1 497 259 094 | 10.2% | 5.4% | -0.2 | -5.1% |
| MEZYM | 23 220 379 | 26.8% | 30.9% | 4.2 | 3 390 460 539 | 32.6% | 22.5% | 2.1 | 9.7% |
| MIG 400 | 10 359 974 | 16.6% | 3.8% | 0.4 | 1 183 670 615 | 18.8% | 2.9% | 0.2 | 5.1% |
| PROSTAMOL | 2 041 447 | -3.7% | 22.7% | -1.9 | 2 732 843 586 | 4.9% | 24.2% | -2.8 | 4.2% |
| RESPERO MYRTOL | 1 234 507 | 114.0% | 8.0% | 3.8 | 568 061 394 | 101.9% | 7.8% | 3 | 11.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 103 158 | -15.4% | 6.2% | -0.3 | 20 082 468 | -15.2% | 5.7% | -0.3 | -11.0% |
| DEXALGIN | 25 580 | -12.1% | 0.7% | -0.1 | 10 826 689 | -13.3% | 1.8% | -0.2 | -4.7% |
| ESPUMISAN (ADULTS) | 70 594 | -11.2% | 56.9% | -0.8 | 35 730 505 | -12.8% | 62.4% | -1.5 | -10.0% |
| ESPUMISAN BABY | 21 984 | -9.1% | 37.9% | -1.5 | 13 854 786 | -9.1% | 50.7% | -1.6 | -5.6% |
| FASTUM | 15 778 | -23.0% | 1.1% | -0.2 | 8 285 315 | -24.7% | 2.4% | -0.6 | -8.7% |
| IODOMARIN | 47 360 | -6.8% | 20.8% | -0.2 | 9 522 204 | -8.0% | 9.7% | 0 | -5.9% |
| LIOTON | 23 072 | -14.8% | 2.4% | -0.2 | 23 896 153 | -16.8% | 4.7% | -0.6 | -6.4% |
| MEZYM | 279 051 | -8.4% | 27.4% | -1.2 | 42 745 664 | -8.3% | 20.1% | -0.5 | -4.5% |
| MIG 400 | 133 655 | -11.0% | 3.7% | -0.3 | 15 660 235 | -11.1% | 2.6% | -0.2 | -4.7% |
| PROSTAMOL | 20 915 | -11.7% | 18.0% | -1.3 | 28 922 942 | -11.8% | 19.3% | -1.4 | -5.5% |
| RESPERO MYRTOL | 9 236 | -8.3% | 7.5% | 0.5 | 4 371 743 | -8.3% | 7.3% | 0.5 | -14.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| DEXALGIN | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| ESPUMISAN (ADULTS) | 336 051 | -12.5% | 56.7% | -0.6 | 172 180 989 | -12.1% | 62.6% | 0.5 | -11.5% |
| ESPUMISAN BABY | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| FASTUM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| IODOMARIN | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| LIOTON | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| MEZYM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| MIG 400 | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| PROSTAMOL | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| RESPERO MYRTOL | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs